Abstract:Background: We have shown that diabetes (DM)-induced cardiac dysfunction and β-adrenergic desensitization were prevented in β 3 -adrenergic receptor (AR) knockout (β 3 KO) mice. However, the molecular mechanism is unclear. We hypothesize that reversal of type 2 (T2) DM-induced alterations of cardiac SR Ca 2+ -ATPase (SERCA2a) and inducible nitric oxide synthase (iNOS) by β 3 KO may play a key role for the protective effect. Methods: LV myocyte protein levels of β 1 - and β 3 -AR, SERCA2a and iNOS, myocyte contractile and [Ca 2+ ] i transient ([Ca 2+ ] iT ) responses to isoproterenol (ISO, 10 -8 M) were compared in 4 groups (n=6) female mice: 2 Vehicle controls wild-type (CWT) and Cβ 3 KO; and 2 T2DM of T2WT and T2β 3 KO.T2 was induced by fed high-fat diet (HFD) for 14 weeks (W), but after HFD for 4 W receiving streptozotocin (STZ, 40 mg/kg/day, i.p. for 5 days). Results: Mice-treated with HFD plus STZ had high blood glucose (~350 to 380 mg/dl). Versus CWT, T2WT myocytes had significantly decreased protein levels of SERCA2a (0.18 vs 0.29), and β 1 -AR (0.35 vs 0.49), but increased iNOS (0.25 vs 0.15) and β 3 -AR (0.25 vs 0.14) with reduced cell contraction (dL/dt max ) (72.7 vs 140.9 μm/s), relaxation (dR/dt max ) (50.9 vs 117.3 μm/s) and [Ca 2+ ] iT (0.16 vs 0.22). Moreover, in T2WT myocytes, ISO caused significantly less increases in dL/dt max (37% vs 59%), dR/dt max (30% vs 53%) and [Ca 2+ ] iT (19% vs 30%). Versus CWT, T2β 3 KO did not alter basal myocyte contraction and relaxation and response to ISO stimulation, but had significantly increased protein levels of SERCA2a (0.38 vs 0.29). T2β 3 KO prevented DM-caused increase in iNOS (T2β 3 KO: 0.16 vs CWT: 0.15) and decrease in β 1 -AR (0.46 vs 0.49). Versus T2β 3 KO, Cβ 3 KO mice had similar alterations. Importantly, in contrast to T2WT, in T2β 3 KO myocytes, the increased SERCA2a and reduced iNOS correlated with normal basal cell contraction and relaxation with preserved ISO-stimulated inotropic response. ISO caused similar increases in dL/dt max (60% vs 59%), dR/dt max (51% vs 53%) and [Ca 2+ ] iT (32% vs 30%). Conclusions: β 3 KO prevents T2DM-caused downregulation of cardiac β 1 -ARs and reverses increased iNOS and decreased SERCA2a, leading to the preservation of myocyte function, [Ca 2+ ] iT , and β-adrenergic reserve. Thus, β 3 -AR may provide a new target for DCM.

Inhibition of Protein Kinase Beta 2 Attenuates Nos Uncoupling and Myocardial Dysfunction in Streptozotocin-Induced Diabetic Rats

Expression Changes Of Mitogen-Actilvated Protelin Kinase Phosphatase-1 (Mkp-1) In Myocardium Of Streptozotocin-Induced Diabetic Rats

Decreased Cardiac Sarcoplasmic Reticulum Ca 2+ -Atpase Activity Contributes to Cardiac Dysfunction in Streptozotocin-Induced Diabetic Rats

Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF-κB/c-fos signaling pathway.

Selective Inhibition Of Pkc Beta 2 Preserves Cardiac Function After Myocardial Infarction And Is Associated With Improved Angiogenesis Of Ischemic Myocardium In Diabetic Rats

Inhibition Of Protein Kinase C Beta Ii Isoform Rescues Glucose Toxicity-Induced Cardiomyocyte Contractile Dysfunction: Role Of Mitochondria

Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes.

Inhibition of Protein Kinase C Βii Isoform Ameliorates Methylglyoxal Advanced Glycation Endproduct-Induced Cardiomyocyte Contractile Dysfunction

Abstract 458: Chronic Inhibition of Protein Kinase C Improves Coronary Endothelial Function in the Setting of Diabetes and Hypoxia

Abstract 12692: Overexpression of Myocardial Inducible Nitric Oxide Synthase Exacerbates Cardiac Dysfunction and Beta-Adrenergic Desensitization in Streptozotocin-Induced Diabetic Mice

Abstract 13385: Protective Effect of Beta3-Adrenergic Receptor Deficiency on Diabetic Cardiomyopathy: Reversal of Type 2 Diabetes-Induced Contrast Changes of Cardiac SERCA 2a and Inducible Nitric Oxide Synthase

Inhibition of CYP2E1 Attenuates Myocardial Dysfunction in a Murine Model of Insulin Resistance Through NLRP3-mediated Regulation of Mitophagy.

Inhibition of Hypothalamic Inhibitor κB Kinase β/Nuclear Transcription Factor κB Pathway Attenuates Metabolism and Cardiac Dysfunction in Type 2 Diabetic Rats

Inhibition of Hypothalamic Inhibitor B Kinase /Nuclear Transcription Factor B Pathway Attenuates Metabolism and Cardiac Dysfunction in Type 2 Diabetic Rats

Inhibition Of Hypothalamic Inhibitor Kappa B Kinase Beta/Nuclear Transcription Factor Kappa B Pathway Attenuates Metabolism And Cardiac Dysfunction In Type 2 Diabetic Rats

Selective inhibition of PTEN preserves ischaemic post-conditioning cardioprotection in STZ-induced Type 1 diabetic rats: role of the PI3K/Akt and JAK2/STAT3 pathways

Abstract 9022: Chronic Beta3-Adrenergic Receptor Antagonist Therapy Rescues Diabetic Cardiomyopathy Through Ca2+/Calmodulin-Dependent Protein Kinase II Inhibition in a Type II Diabetes Murine Model

THE EFFECT OF PHYCOCYANIN ON THE EXPRESSION OF Inos IN MYOCARDIAL CELLS OF TYPE 2 DIABETES MELLITUS IN RATS

NADPH Oxidase Inhibition Alleviates Diabetes‐Induced Myocardial Contractile Dysfunction

Role of CK1ε-regulated PERIOD2 in STZ-induced Diabetic Myocardial Injury.

Catalase Alleviates Cardiomyocyte Dysfunction in Diabetes: Role of Akt, Forkhead Transcriptional Factor and Silent Information Regulator 2